Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial

Nina W. van der Hoeven, Gladys N. Janssens, Henk Everaars, Alexander Nap, Jorrit S. Lemkes, Guus A. de Waard, Peter M. van de Ven, Albert C. van Rossum, Javier Escaned, Hernan Mejia‐Renteria, Tim J. F. ten Cate, Jan J. Piek, Clemens von Birgelen, Marco Valgimigli, Roberto Diletti, Niels P. Riksen, Nicolas M. Van Mieghem, Robin Nijveldt, Maarten A. H. van Leeuwen, Niels van Royen

Open source

DOI
10.1161/jaha.119.014411
Published
2020-03-03
Container
Journal of the American Heart Association
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/jaha.119.014411,
  title = {Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial},
  author = {Nina W. van der Hoeven and Gladys N. Janssens and Henk Everaars and Alexander Nap and Jorrit S. Lemkes and Guus A. de Waard and Peter M. van de Ven and Albert C. van Rossum and Javier Escaned and Hernan Mejia‐Renteria and Tim J. F. ten Cate and Jan J. Piek and Clemens von Birgelen and Marco Valgimigli and Roberto Diletti and Niels P. Riksen and Nicolas M. Van Mieghem and Robin Nijveldt and Maarten A. H. van Leeuwen and Niels van Royen},
  year = {2020},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.119.014411},
  url = {https://doi.org/10.1161/jaha.119.014411}
}

RIS

TY  - JOUR
TI  - Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial
AU  - Nina W. van der Hoeven
AU  - Gladys N. Janssens
AU  - Henk Everaars
AU  - Alexander Nap
AU  - Jorrit S. Lemkes
AU  - Guus A. de Waard
AU  - Peter M. van de Ven
AU  - Albert C. van Rossum
AU  - Javier Escaned
AU  - Hernan Mejia‐Renteria
AU  - Tim J. F. ten Cate
AU  - Jan J. Piek
AU  - Clemens von Birgelen
AU  - Marco Valgimigli
AU  - Roberto Diletti
AU  - Niels P. Riksen
AU  - Nicolas M. Van Mieghem
AU  - Robin Nijveldt
AU  - Maarten A. H. van Leeuwen
AU  - Niels van Royen
PY  - 2020
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.119.014411
UR  - https://doi.org/10.1161/jaha.119.014411
ER  - 

APA

Hoeven, N. W. V. D., Janssens, G. N., Everaars, H., Nap, A., Lemkes, J. S., Waard, G. A. D., Ven, P. M. V. D., Rossum, A. C. V., Escaned, J., Mejia‐Renteria, H., Cate, T. J. F. T., Piek, J. J., Birgelen, C. V., Valgimigli, M., Diletti, R., Riksen, N. P., Mieghem, N. M. V., Nijveldt, R., Leeuwen, M. A. H. V., & Royen, N. V. (2020). Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.119.014411

Source records